Tue, September 10, 2024

Edward Nash Maintained (TVTX) at Strong Buy with Increased Target to $23 on, Sep 10th, 2024

Edward Nash of Canaccord Genuity, Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Increased Target from $18 to $23 on, Sep 10th, 2024.

Edward has made no other calls on TVTX in the last 4 months.



There are 8 other peers that have a rating on TVTX. Out of the 8 peers that are also analyzing TVTX, 1 agrees with Edward's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Allison Bratzel of "Piper Sandler" Maintained at Hold with Increased Target to $12 on, Friday, August 2nd, 2024


These are the ratings of the 7 analyists that currently disagree with Edward


  • Vamil Divan of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $25 on, Monday, September 9th, 2024
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $23 on, Friday, September 6th, 2024
  • Greg Harrison of "B of A Securities" Maintained at Strong Buy with Increased Target to $19 on, Friday, September 6th, 2024
  • Carly Kenselaar of "Citigroup" Maintained at Strong Buy with Increased Target to $23 on, Friday, September 6th, 2024
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $20 on, Tuesday, August 13th, 2024
  • Carter Gould of "Barclays" Maintained at Buy with Increased Target to $14 on, Friday, August 2nd, 2024
  • Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $16 on, Friday, August 2nd, 2024